Oct 12, 2002
If one finds out that he is acutely hiv infected within the past 3 months, what is your opinion on whether to start treatment at this stage vs. waiting until numbers deteriorate?
| Response from Dr. Wohl
When people are still in the stages of acute infection and have not fully seroconverted, meaning the ELISA and Western blot tests are not both positive for HIV, there is early evidence that HIV therapy can be beneficial in keeping the viral load low even after therapy is stopped later on. The idea is that early treatment during acute infection might help preserve the body's specific immune responses to HIV.
In cases where the individual has already HIV seroconverted most clinicians would probably look at the CD4 count and HIV viral load trends before deciding to initiate therapy.
There are gray areas between acute infection and established infection such as when the HIV antibody tests give borderline results. In these situations treatment is considered on an individual basis. If at all possible, treatment of acute or early HIV infection should be done in a research setting as part of a clinical trial. DW
Get Email Notifications When This Forum Updates or Subscribe With RSS
- What Does It Mean To Be Exposed To Herpes?
- What Is The Time Duration Of Shingles?
- What Is The Percentage For Positive Herpes Simplex Type 1?
- What Is The Difference Between Syphilis And Herpes?
- What Can I Use Over The Counter To Treat Bacterial Vaginosis?
- What Are Physical Symptoms Of Genital Herpes?
This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.
Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.